8-KFinancial EventsExhibits & Filings

Edwards Lifesciences Corp 8-K Report, Financial Obligation (Jun 18, 2013)

Filed June 18, 2013For Securities:EW

Summary

Edwards Lifesciences Corporation (EW) has filed an 8-K report on June 17, 2013, detailing an amendment to its existing Four Year Credit Agreement. The primary focus of this amendment, effective June 13, 2013, is the exercise of an "accordion feature" to increase the company's aggregate borrowing capacity. This strategic move raises the total credit facility from $500.0 million to $750.0 million, representing a significant $250.0 million expansion.

Key Highlights

  • 1Edwards Lifesciences exercised an "accordion feature" to increase its credit facility.
  • 2The total credit commitment has been expanded by $250.0 million.
  • 3The aggregate credit commitment now stands at $750.0 million, up from $500.0 million.
  • 4This amendment is to the Four Year Credit Agreement originally dated July 29, 2011.
  • 5The amendment was entered into on June 13, 2013.
  • 6The filing indicates robust access to capital and potential for future investment or operational needs.
  • 7Key financial institutions, including Bank of America, JPMorgan Chase, and Wells Fargo, are involved as agents in the credit agreement.

Frequently Asked Questions

While the filing doesn't explicitly state the reasons, increasing a credit facility often signifies a company's proactive approach to securing additional capital for potential future investments, acquisitions, working capital needs, or to maintain financial flexibility in a dynamic market.

An "accordion feature" is a provision in a loan agreement that allows a borrower to increase the amount they can borrow up to a certain limit, without having to renegotiate the entire agreement. It provides flexibility to expand borrowing as needed.

For investors, an increased credit line can be interpreted positively, suggesting the company anticipates growth opportunities or is strengthening its financial position. It demonstrates confidence in its ability to manage and repay larger debt obligations, though it also implies a potential for increased leverage.

The amendment involves Edwards Lifesciences as the borrower, along with certain subsidiaries. Major financial institutions acting as agents include Bank of America, N.A. (Administrative Agent), JPMorgan Chase Bank, N.A., and Wells Fargo Bank, National Association (Co-Syndication Agents), and U.S. Bank National Association, The Bank of Tokyo-Mitsubishi UFJ, Ltd., Deutsche Bank AG New York Branch, and Mizuho Corporate Bank, Ltd. (Co-Documentation Agents).